SCHEMBL12484199

SCHEMBL12484199

Cc1cc(N2CCCC2)nc(Nc2ccc(F)cc2)n1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.63
KMT2A Q03164 3/20 0.63
ALDH1A1 P00352 3/20 0.63
MAPT P10636 3/20 0.63
MAPK1 P28482 2/20 0.63
KDM4E B2RXH2 2/20 0.63
TDP1 Q9NUW8 2/20 0.63
GAA P10253 1/20 0.63
ALOX15 P16050 1/20 0.63
NR4A1 P22736 1/20 0.63
SLC2A1 P11166 3/20 0.58
GALR2 O43603 8/20 0.55
AURKA O14965 1/20 0.53
AURKB Q96GD4 1/20 0.53
CYP1A2 P05177 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C19 P33261 1/20 0.52
HTT P42858 1/20 0.52
BLM P54132 2/20 0.50
TP53 P04637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12486733 0.99 ALDH1A1 (0.62) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL12485635 0.99 ALDH1A1 (0.62) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL12484612 0.97 MEN1 (0.59) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL12486690 0.89 AURKA (0.65) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL12485812 0.89 MAPT (0.64) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL12486039 0.88 MAPT (0.67) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL12486589 0.88 BPTF (0.54) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL20042146 0.87 MAPT (0.65) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL12486475 0.87 SLC2A1 (0.49) MEN1KMT2AALDH1A1MAPTMAPK1
SCHEMBL12485669 0.86 MEN1 (0.49) MEN1KMT2AALDH1A1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9890138-B2 Diaminopyrimidine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2018-02-13 US claimed
EP-2678332-B1 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2016-05-18 EP claimed
US-20150274700-A2 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2015-10-01 US claimed
CN-103402997-B Diaminopyrimidine derivatives and process for preparing same Liu Hanyangxing (KR) 2015-08-26 CN claimed
EP-2678332-A2 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF Yuhan Corporation (KR) 2014-01-01 EP claimed
US-20130338179-A1 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2013-12-19 US claimed
CN-103402997-A Diaminopyrimidine derivatives and process for preparing same YUHAN INC 2013-11-20 CN claimed
WO-2012115480-A2 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2012-08-30 WO claimed
US-10227330-B2 Diaminopyrimidine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2019-03-12 US disclosed
US-20180111918-A1 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2018-04-26 US disclosed
US-9890138-B2 Diaminopyrimidine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2018-02-13 US disclosed
EP-2678332-B1 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2016-05-18 EP disclosed
US-20150274700-A2 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2015-10-01 US disclosed
CN-103402997-B Diaminopyrimidine derivatives and process for preparing same Liu Hanyangxing (KR) 2015-08-26 CN disclosed
EP-2678332-A2 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF Yuhan Corporation (KR) 2014-01-01 EP disclosed
US-20130338179-A1 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2013-12-19 US disclosed
CN-103402997-A Diaminopyrimidine derivatives and process for preparing same YUHAN INC 2013-11-20 CN disclosed
WO-2012115480-A2 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2012-08-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150274700-A2 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF HRH2, GIPR, SSTR4 MEN1 4759/4885KMT2A 4017/4885ALDH1A1 3199/4885
US-20130338179-A1 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF HRH2, GIPR, SSTR4 MEN1 4759/4885KMT2A 4017/4885ALDH1A1 3199/4885
US-20180111918-A1 DIAMINOPYRIMIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF HRH2, GIPR, SSTR4 MEN1 4759/4885KMT2A 4017/4885ALDH1A1 3199/4885
US-10227330-B2 Diaminopyrimidine derivatives and processes for the preparation thereof HRH2, GIPR, SSTR4 MEN1 4759/4885KMT2A 4017/4885ALDH1A1 3199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.